Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles.

Song JM, Kim YC, Barlow PG, Hossain MJ, Park KM, Donis RO, Prausnitz MR, Compans RW, Kang SM.

Antiviral Res. 2010 Nov;88(2):244-7. doi: 10.1016/j.antiviral.2010.09.001. Epub 2010 Sep 21.

2.

Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice.

Song JM, Kim YC, Lipatov AS, Pearton M, Davis CT, Yoo DG, Park KM, Chen LM, Quan FS, Birchall JC, Donis RO, Prausnitz MR, Compans RW, Kang SM.

Clin Vaccine Immunol. 2010 Sep;17(9):1381-9. doi: 10.1128/CVI.00100-10. Epub 2010 Jul 14.

3.

Long-term protective immunity from an influenza virus-like particle vaccine administered with a microneedle patch.

Quan FS, Kim YC, Song JM, Hwang HS, Compans RW, Prausnitz MR, Kang SM.

Clin Vaccine Immunol. 2013 Sep;20(9):1433-9. doi: 10.1128/CVI.00251-13. Epub 2013 Jul 17.

4.

Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization.

Quan FS, Kim YC, Vunnava A, Yoo DG, Song JM, Prausnitz MR, Compans RW, Kang SM.

J Virol. 2010 Aug;84(15):7760-9. doi: 10.1128/JVI.01849-09. Epub 2010 May 19.

5.

Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles.

Song JM, Hossain J, Yoo DG, Lipatov AS, Davis CT, Quan FS, Chen LM, Hogan RJ, Donis RO, Compans RW, Kang SM.

Virology. 2010 Sep 15;405(1):165-75. doi: 10.1016/j.virol.2010.05.034. Epub 2010 Jun 26.

6.

Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection.

Kim MC, Lee JW, Choi HJ, Lee YN, Hwang HS, Lee J, Kim C, Lee JS, Montemagno C, Prausnitz MR, Kang SM.

J Control Release. 2015 Jul 28;210:208-16. doi: 10.1016/j.jconrel.2015.05.278. Epub 2015 May 21.

7.

Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles.

Quan FS, Kim YC, Compans RW, Prausnitz MR, Kang SM.

J Control Release. 2010 Nov 1;147(3):326-32. doi: 10.1016/j.jconrel.2010.07.125. Epub 2010 Aug 6.

9.
10.

Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.

Beljanski V, Chiang C, Kirchenbaum GA, Olagnier D, Bloom CE, Wong T, Haddad EK, Trautmann L, Ross TM, Hiscott J.

J Virol. 2015 Oct;89(20):10612-24. doi: 10.1128/JVI.01526-15. Epub 2015 Aug 12.

11.

Cocktail of H5N1 COBRA HA vaccines elicit protective antibodies against H5N1 viruses from multiple clades.

Crevar CJ, Carter DM, Lee KY, Ross TM.

Hum Vaccin Immunother. 2015;11(3):572-83. doi: 10.1080/21645515.2015.1012013.

12.

Protective efficacy of baculovirus-derived influenza virus-like particles bearing H5 HA alone or in combination with M1 in chickens.

Choi JG, Kim MC, Kang HM, Kim KI, Lee KJ, Park CK, Kwon JH, Kim JH, Lee YJ.

Vet Microbiol. 2013 Mar 23;162(2-4):623-30. doi: 10.1016/j.vetmic.2012.11.035. Epub 2012 Nov 29.

PMID:
23265240
13.

Antibody breadth and protective efficacy are increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin-based H5N1 virus-like particle vaccines.

Giles BM, Bissel SJ, Dealmeida DR, Wiley CA, Ross TM.

Clin Vaccine Immunol. 2012 Feb;19(2):128-39. doi: 10.1128/CVI.05533-11. Epub 2011 Dec 21.

14.

Improved influenza vaccination in the skin using vaccine coated microneedles.

Kim YC, Quan FS, Yoo DG, Compans RW, Kang SM, Prausnitz MR.

Vaccine. 2009 Nov 16;27(49):6932-8. doi: 10.1016/j.vaccine.2009.08.108. Epub 2009 Sep 15.

15.

DNA vaccination in the skin using microneedles improves protection against influenza.

Song JM, Kim YC, O E, Compans RW, Prausnitz MR, Kang SM.

Mol Ther. 2012 Jul;20(7):1472-80. doi: 10.1038/mt.2012.69. Epub 2012 Apr 17.

16.
17.

Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice.

Quan FS, Vunnava A, Compans RW, Kang SM.

PLoS One. 2010 Feb 11;5(2):e9161. doi: 10.1371/journal.pone.0009161.

18.

Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles.

Kim YC, Yoo DG, Compans RW, Kang SM, Prausnitz MR.

J Control Release. 2013 Dec 10;172(2):579-88. doi: 10.1016/j.jconrel.2013.04.016. Epub 2013 Apr 30.

19.

Protection induced by early stage vaccination with pandemic influenza virus-like particles.

Lee GJ, Quan FS.

Vaccine. 2016 Jul 19;34(33):3764-72. doi: 10.1016/j.vaccine.2016.06.011. Epub 2016 Jun 15.

PMID:
27317263
20.

Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch.

Kim YC, Song JM, Lipatov AS, Choi SO, Lee JW, Donis RO, Compans RW, Kang SM, Prausnitz MR.

Eur J Pharm Biopharm. 2012 Jun;81(2):239-47. doi: 10.1016/j.ejpb.2012.03.010. Epub 2012 Apr 3.

Supplemental Content

Support Center